In this study, we have addressed the presence and distribution of CD4+ T cells specific for the tumor antigen ESO, of the cancer/testis group [10], [30], [31], within circulating CD4+ T-cell subsets of EOC patients. The gene discussed is CD4; the disease is cancer.